4 edition of study of patients on chronic haemodialysis found in the catalog.
study of patients on chronic haemodialysis
|Statement||Elisabeth Bergsten, Hiroyuki Asaba and Jonas Bergström.|
|Series||Scandinavian journal of social medicine : Supplementum ;, 11, Scandinavian journal of social medicine., 11.|
|Contributions||Asaba, Hiroyuki, joint author., Bergström, Jonas, 1929- joint author.|
|LC Classifications||RC901.7.A7 B38|
|The Physical Object|
|Pagination||31 p. :|
|Number of Pages||31|
|LC Control Number||78318043|
However, since haemodialysis patients are prone to hyperkalaemia, a known side effect of spironolactone, this treatment is not used in this population. We performed a study to assess whether low-dose spironolactone (3 x 25 mg/week) could be administered without inducing hyperkalaemia in haemodialysis :// DISCUSSION: Cutaneous manifestations in patients with chronic renal failure on haemodialysis was found to be present in 99% of patients in the present study. This is comparable to other studies including the study conducted by Udaykumar et al (5) and Pico et al (2) who had documented cutaneous disorders in all the patients (%) in the ://+clinical+study+of+cutaneous+manifestations+of+chronic.
Chronic kidney disease (CKD)-associated pruritus is a common adverse symptom in patients with end-stage renal disease treated by dialysis. Herein, a systematic review and meta-analysis of the PURPOSE: Chronic itch (CI) is a common symptom in haemodialysis (HD) patients affecting about every 4th HD patient. Though it is known that health-related quality of life (HRQOL) is impaired in HD patients, data are lacking on how CI influences HRQOL in this group of patients, also regarding sex differences and the role of sleep and ://
One hundred seventy patients, undergoing maintenance hemodialysis and 15 undergoing chronic peritoneal dialysis, were examined. Inclusion criteria included dialysis vintage of at least 6 months. Patients completed the Beck Anxiety Inventory and Beck Depression Inventory and questionnaires that examined their feelings of anxiety related to in chronic haemodialysis patients: a study with second-generation assays F. Fabrizi1, L. Raffaele2, G. Bacchini1, I. Guarnori2, G. Pontoriero1, G. Erba2, and F. Locatelli1 'Department of Nephrology and 2Transfusion Centre, Hospital, Lecco, Italy Abstract. We used first- and second-generation assays such as Ortho 1, Ortho 2 and 4-RIBA to ?doi=&rep=rep1&type=pdf.
Randy, Cactus & Uncle Ed
Helping aggressive and passive preschoolers through play
The Oxford handbook of economic geography
Geological Society of America Archives Online (1988-2001). Geology and GSA Bulletin Online Archives [electronic resource]
On polysynthesis and incorporation
Special symposium on atmospheric research in Canada in honour of Dr. Warren L. Godsons fifty years of public service
Despatches from United States consuls in Rosario, 1858-1906
River Taw catchment management plan
The One-Legged, Bow-Legged Cricket
Introduction. The prevalence of chronic kidney disease is increasing worldwide, and is expected to continue increasing.1 There are five stages of chronic kidney disease, with end-stage renal disease (ESRD) its final stage.
With worsening of their kidney disease, patients develop many complications associated with a high risk of comorbidities and mortality.2–4 Therefore, health care A more recent study showed increased levels of epidermal calcium in chronic haemodialysis patients with uremic pruritus.
Another study found a higher incidence of uremic pruritus in dialysis patients with significant elevation of calcium, phosphate and A total of 2, patients from centres in 25 countries were randomised into the study.
Patients aged 50–80 years on regular chronic haemodialysis for at least 3 months before screening were eligible for inclusion. They were randomised to receive either rosuvastatin 10 mg or placebo daily and assessed throughout the :// Patients on chronic haemodialysis (HD) have a higher incidence of cancer.
However, the risk of skin cancer in this population has rarely been investigated. Objectives. To investigate the risk of nonmelanoma skin cancer (NMSC) and cutaneous melanoma in patients on chronic HD and to explore the associated risk factors. Methods 1. Scand J Soc Med Suppl.
; A study of patients on chronic haemodialysis. A sociomedical investigation of the experiences of patients on haemodialysis and their quality of :// Patients and Methods: One hundred patients of either gender were included in this study.
Fifty patients of chronic kidney disease stage V on hemodialysis were taken for echocardiography and fifty were normal. Echocardiography was done for cardiac dysfunction.
haemodialysis patients as compared to controls as in ours A study, conducted on A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis Nephrol Dial Transplant.
Dec;24(12) doi: /ndt/gfp This is the first study analysing the quality of OAT control in patients treated with phenprocoumon in a chronic haemodialysis population. The median percentage of INR measurements in the target range was around 50% and comparable with previously published data on OAT control with warfarin and acenocoumarol in ESRD (37–50% in target range Seven patients with chronic renal failure treated with haemodialysis for 4 to 24 months were found to have low exchangeable potassium levels.
Before dialysis the plasma potassium was normal or somewhat raised (possibly owing to acidosis), though the exchangeable potassium was low.
Acidosis was corrected during dialysis; plasma potassium levels fell, but clinical and electrocardiographic It is widely known that haemodialysis patients do not readily comply with nutrition guidance. At least 6 months after initiating haemodialysis, the patients' dietary knowledge was tested by use of a questionnaire.
The relationship between patient dietary compliance and religion and educational level -nine patients undergoing routine haemodialysis for chronic renal failure were followed radiologically for the presence of osteodystrophy. At holiday haemodialysis and expansion in patient numbers calculation of the required number of haemodialysis stations should be based on using each station for 2 patients per day three times per week.
The national average number of hospital haemodialysis patients per million Chronic Renal Failure (CRF) patients are at risk of cardiovascular diseases due to the elevation of various forms of lipids.
Many a time CRF patients live on hemodialysis on regular :// Our study describes QoL, as well as demographic and clinical variables associated with QoL in chronic haemodialysis (HD) patients in Romania.
Methods. All prevalent chronic HD patients (N = ; mean age ± years) in 12 dialysis centres from the three main regions of Romania were included in the :// To date, no in-depth study of haemodialysis patients’ emotional responses to conditions of their treatment A descriptive exploratory qualitative study using content analysis was '_experiences_of_safety.
The study had a descriptive design and qualitative content analysis was used to search for themes based on descriptions contained in the collected nursing documentation. Methods. The total number of nursing records of patients receiving chronic haemodialysis treatment (n = 50) for the 5‐year period – was included.
All nursing A study to evaluate the Use of Rosuvastatin in subjects On Regular haemodialysis: an Assessment of survival and cardiovascular events (AURORA) will be the first large-scale international trial to assess the effects of statin therapy on cardiovascular morbidity and mortality in ESRD patients on chronic haemodialysis.
Methods More 18 Muhammed Sanoop A. et al.: Comparative Study of Lipid Profile in Patients with Chronic Kidney Disease on Haemodialysis / Conservative Management with Control Population patients with CKD in all stages with patient on conservative management and on haemodialysis.
Age matched healthy persons were selected as control group. All the ?doi=/ Background: Iron deficiency is frequent in haemodialysis (HD) patients with chronic kidney disease (CKD), and intravenous iron is an established therapy for these patients.
This study assessed treatment routine, effectiveness, and safety of iron isomaltoside (IIM) 5% (Diafer®) in a HD :// A study to evaluate the Use of Rosuvastatin in subjects On Regular haemodialysis: an Assessment of survival and cardiovascular events (AURORA) will be the first large-scale international trial to assess the effects of statin therapy on cardiovascular morbidity and mortality in ESRD patients on chronic haemodialysis.
More than 2, ESRD. Exchangeable Potassium Study in Patients Undergoing Chronic Haemodialysis Article (PDF Available) in British Medical Journal 2() June with 13 Reads How we measure 'reads'A study to evaluate the Use of Rosuvastatin in subjects On Regular haemodialysis: an Assessment of survival and cardiovascular events (AURORA) will be the first large-scale international trial to assess the effects of statin therapy on cardiovascular morbidity and mortality in ESRD patients on chronic ://This is a randomised clinical study over 12 months involving 40 patients on haemodialysis, comparing the effect of HFR (n=25) dialysis with haemodialysis with polysulfone (HD-PS, n=15) on